131 related articles for article (PubMed ID: 24709195)
1. Aspirin and esophageal squamous cell carcinoma: bedside to bench.
Li P; Cheng R; Zhang S
Chin Med J (Engl); 2014; 127(7):1365-9. PubMed ID: 24709195
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma.
Sun L; Yu S
Dis Esophagus; 2011 Nov; 24(8):544-9. PubMed ID: 21539676
[TBL] [Abstract][Full Text] [Related]
3. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.
Corley DA; Kerlikowske K; Verma R; Buffler P
Gastroenterology; 2003 Jan; 124(1):47-56. PubMed ID: 12512029
[TBL] [Abstract][Full Text] [Related]
4. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
5. NSAIDS and esophageal cancer.
Scherübl H; Sutter AP; Zeitz M
Gastroenterology; 2003 Dec; 125(6):1914-5; author reply 1915. PubMed ID: 14727630
[No Abstract] [Full Text] [Related]
6. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Muranushi C; Olsen CM; Pandeya N; Green AC
J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
[TBL] [Abstract][Full Text] [Related]
7. COX-2 mRNA expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID.
Liu X; Li P; Zhang ST; You H; Jia JD; Yu ZL
Dis Esophagus; 2008; 21(1):9-14. PubMed ID: 18197933
[TBL] [Abstract][Full Text] [Related]
8. Regular aspirin use and esophageal cancer risk.
Jayaprakash V; Menezes RJ; Javle MM; McCann SE; Baker JA; Reid ME; Natarajan N; Moysich KB
Int J Cancer; 2006 Jul; 119(1):202-7. PubMed ID: 16450404
[TBL] [Abstract][Full Text] [Related]
9. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib.
Limburg PJ; Wei W; Ahnen DJ; Qiao Y; Hawk ET; Wang G; Giffen CA; Wang G; Roth MJ; Lu N; Korn EL; Ma Y; Caldwell KL; Dong Z; Taylor PR; Dawsey SM
Gastroenterology; 2005 Sep; 129(3):863-73. PubMed ID: 16143126
[TBL] [Abstract][Full Text] [Related]
10. Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway.
Zhou QZ; Liu HB; Ding XC; Li P; Zhang ST; Yu ZL
Chin Med J (Engl); 2007 Dec; 120(23):2086-91. PubMed ID: 18167181
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
Wang F; Lv ZS; Fu YK
Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and reduced risk of esophageal carcinoma.
Funkhouser EM; Sharp GB
Cancer; 1995 Oct; 76(7):1116-9. PubMed ID: 8630885
[TBL] [Abstract][Full Text] [Related]
13. Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention.
Li M; Lotan R; Levin B; Tahara E; Lippman SM; Xu XC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):545-9. PubMed ID: 10868686
[TBL] [Abstract][Full Text] [Related]
14. Estrogen analogues: promising target for prevention and treatment of esophageal squamous cell carcinoma in high risk areas.
Wang QM; Yuan L; Qi YJ; Ma ZY; Wang LD
Med Sci Monit; 2010 Jul; 16(7):HY19-22. PubMed ID: 20581783
[TBL] [Abstract][Full Text] [Related]
15. Effect of taking aspirin before diagnosis on the prognosis of esophageal squamous cell carcinoma and analysis of prognostic factors.
Jiang J; Liu J; Gao P; Liu J
J Int Med Res; 2022 Apr; 50(4):3000605221089799. PubMed ID: 35400214
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
[TBL] [Abstract][Full Text] [Related]
17. Low dose aspirin prevents duodenoesophageal reflux induced mucosal changes in wistar rat esophagus by MAP kinase mediated pathways.
Selvan B; Ramachandran A; Korula A; Amirtharaj GJ; Kettimuthu K; Nair S; Nair A; Samuel P; Mathew G
Int J Surg; 2012; 10(2):73-9. PubMed ID: 22197650
[TBL] [Abstract][Full Text] [Related]
18. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
[TBL] [Abstract][Full Text] [Related]
19. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
[TBL] [Abstract][Full Text] [Related]
20. Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.
Li LY; Jiang H; Xie YM; Liao LD; Cao HH; Xu XE; Chen B; Zeng FM; Zhang YL; Du ZP; Chen H; Huang W; Jia W; Zheng W; Xie JJ; Li EM; Xu LY
Oncotarget; 2015 Jun; 6(18):15940-52. PubMed ID: 25909284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
